Monitor for a Schedule 13D filing, which would detail Tang Capital's intentions (e.g., pushing for a sale, board changes, or strategic review). The stake size (~2.8% of shares outstanding at $239M market cap) is significant enough to command attention. Look for increased trading volume and potential short squeeze given the high bearish analyst sentiment.
Price Chart
Executive Summary
Kevin Tang and Tang Capital Management LLC filed a Form 3 initial statement of beneficial ownership, disclosing a 6,663,383-share stake in Fulcrum Therapeutics. This represents a new, significant position by a known activist investor, suggesting potential strategic engagement at a beaten-down biotech with a $239M market cap and largely negative analyst consensus.
Key Facts
- Kevin Tang and Tang Capital Management LLC filed Form 3 on 2026-07-15, reporting beneficial ownership of 6,663,383 shares of FULC common stock.
- The shares are held indirectly through Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc.
- Kevin Tang is the sole manager/director/CEO of the reporting entities, giving him control and pecuniary interest in the stake.
- The filing is an initial statement, indicating a new position by Tang Capital, a known activist investment firm.
- FULC has a $239M market cap and 0% analyst bullish rating (7 hold, 4 sell, 2 strong sell).
Financial Impact
6,663,383 shares of FULC common stock disclosed; no specific dollar value for the stake is provided in the filing.
Risk Factors
- Tang Capital's intentions are unclear from this Form 3 alone; no 13D has been filed yet.
- FULC has a poor historical track record — past reports on this ticker showed average negative returns at T+20, so the market may be skeptical of activist catalysts.
- The company's weak fundamentals and negative analyst consensus could limit upside if Tang Capital fails to drive a clear outcome.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (FULC) — Batch item 1 | 0001178579-26-000013 |
| Document: 0001178579-26-000013-index.html | 0001178579-26-000013 |
| Document: 0001178579-26-000013.txt | 0001178579-26-000013 |
| 3 Filing (FULC) — Batch item 4 | 0001178579-26-000013 |
| Document: 0001178579-26-000013-index.html | 0001178579-26-000013 |
| Document: 0001178579-26-000013.txt | 0001178579-26-000013 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | S-4 | $3.85 $3.70 | ▲ +3.90% | ▲ +3.57% | $3.67 (+4.68%) |
Aug 17, 2026 6w ago | 425 | $3.84 $3.78 | ▲ +1.56% | ▼ −0.42% | $3.67 (+4.43%) |
Aug 17, 2026 6w ago | 425 | $3.84 $3.78 | ▼ −1.56% | ▲ +0.42% | $3.67 (−4.43%) |
Aug 17, 2026 6w ago | 8-K | $3.84 $3.78 | ▼ −1.56% | ▲ +0.42% | $3.67 (−4.43%) |
Aug 17, 2026 6w ago | Press Release | $3.84 $3.78 | ▼ −1.56% | ▲ +0.42% | $3.67 (−4.43%) |
Aug 10, 2026 7w ago | 8-K | $3.75 $3.82 | ▲ +1.87% | ▲ +2.78% | $3.67 (−2.13%) |
Jul 15, 2026 11w ago | 3 | $3.50 $3.71 | ▲ +6.00% | ▲ +2.38% | $3.67 (+4.86%) |
Jun 11, 2026 16w ago | Institutional Cluster | $3.55 $3.59 | ▲ +1.13% | ▼ −0.76% | $3.67 (+3.38%) |
Apr 27, 2026 22w ago | 8-K | $7.72 $6.76 | ▼ −12.44% | ▼ −17.39% | $3.67 (−52.46%) |
Apr 27, 2026 22w ago | Press Release | $7.72 $6.76 | ▼ −12.44% | ▼ −17.39% | $3.67 (−52.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access